|
US4684620A
(en)
|
1984-09-04 |
1987-08-04 |
Gibson-Stephens Neuropharmaceuticals, Inc. |
Cyclic polypeptides having mu-receptor specificity
|
|
US4724229A
(en)
|
1986-09-30 |
1988-02-09 |
Smithkline Beckman Corporation |
Arg-arg-arg-vasopressin antagonists
|
|
JPH02306947A
(ja)
|
1989-05-01 |
1990-12-20 |
Monsanto Co |
キラルβ―アミノ酸の製造方法
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
AU666853B2
(en)
|
1991-04-05 |
1996-02-29 |
Genentech Inc. |
Platelet aggregation inhibitors having high specificity for GP IIbIIIa
|
|
CZ168194A3
(en)
|
1992-11-12 |
1994-12-15 |
Biomeasure |
Opioid peptides
|
|
US5293050A
(en)
|
1993-03-25 |
1994-03-08 |
International Business Machines Corporation |
Semiconductor quantum dot light emitting/detecting devices
|
|
AU673731B2
(en)
*
|
1993-06-03 |
1996-11-21 |
Banyu Pharmaceutical Co., Ltd. |
Novel endothelin antagonistic peptide
|
|
GB9516994D0
(en)
|
1995-08-18 |
1995-10-18 |
Iaf Biochem Int |
Solution synthesis of peripheral acting analgestic opioid tetrapeptides
|
|
US6037324A
(en)
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
US5990084A
(en)
|
1996-04-19 |
1999-11-23 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7122623B2
(en)
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5942492A
(en)
|
1996-11-12 |
1999-08-24 |
Angstrom Pharmaceuticals, Inc. |
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
|
US5993811A
(en)
|
1997-02-03 |
1999-11-30 |
Biology Associates, Llc |
Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
|
|
JP2001509493A
(ja)
|
1997-07-11 |
2001-07-24 |
インナーダイン， インコーポレイテッド |
放射送達構造体の調製およびシール化のための方法およびシステム
|
|
US6818617B1
(en)
|
1997-08-15 |
2004-11-16 |
Temple University- Of The Commonwealth System Of Higher Education |
EC-3, an inhibitor of α4β1 and α4β7 integrins
|
|
AU750175B2
(en)
|
1997-11-24 |
2002-07-11 |
Merck & Co., Inc. |
Cyclic amino acid derivatives as cell adhesion inhibitors
|
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
US6248057B1
(en)
|
1998-07-28 |
2001-06-19 |
Innerdyne, Inc. |
Absorbable brachytherapy and chemotherapy delivery devices and methods
|
|
EP1105427A2
(en)
|
1998-08-17 |
2001-06-13 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
|
US6087334A
(en)
|
1998-08-21 |
2000-07-11 |
Amylin Pharmaceuticals, Inc. |
Anti-diabetic peptides
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
AUPP616598A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Auxiliary for amide bond formation
|
|
AUPP660698A0
(en)
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
|
US6451987B1
(en)
|
1999-03-15 |
2002-09-17 |
Novo Nordisk A/S |
Ion exchange chromatography of proteins and peptides
|
|
CZ20013018A3
(cs)
|
1999-03-17 |
2002-02-13 |
Novo Nordisk A/S |
Způsob pro acylování aminoskupiny peptidu nebo proteinu a sloučenina
|
|
ES2231179T3
(es)
|
1999-04-12 |
2005-05-16 |
Aventis Pharma Limited |
Compuestos de heteroarilo biciclicos sustituidos como antagonistas de la integrina.
|
|
WO2001068586A2
(en)
|
2000-03-14 |
2001-09-20 |
Novartis Ag |
α4β1 AND α4β7 INTEGRIN INHIBITORS
|
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
KR100983997B1
(ko)
|
2001-01-09 |
2010-09-28 |
메르크 파텐트 게엠베하 |
수용체 타이로신 키나아제 저해제 및 혈관형성 저해제를 사용하는 병용 요법
|
|
DE10107707A1
(de)
|
2001-02-19 |
2002-08-29 |
Wilex Biotechnology Gmbh |
Antagonisten für alpha¶4¶beta¶7¶-Integrin
|
|
AUPS039702A0
(en)
|
2002-02-08 |
2002-03-07 |
University Of Queensland, The |
Common protein surface shapes and uses therefor
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
US7265093B2
(en)
|
2002-05-14 |
2007-09-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Drug therapy for Celiac Sprue
|
|
WO2004011650A2
(en)
|
2002-07-24 |
2004-02-05 |
Intercell Ag |
Antigens encoded by alternative reading frame from pathogenic viruses
|
|
US20040176293A1
(en)
|
2002-12-18 |
2004-09-09 |
Wyeth |
Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
AU2004231122B2
(en)
|
2003-04-15 |
2010-04-08 |
Xenon Pharmaceuticals Inc. |
Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
|
|
ES2586387T3
(es)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
|
|
US20060030053A1
(en)
|
2003-12-19 |
2006-02-09 |
Applera Corporation |
Methods and systems for protein and peptide evidence assembly
|
|
MX370489B
(es)
|
2004-01-09 |
2019-12-16 |
Pfizer |
Anticuerpos contra madcam.
|
|
US8536140B2
(en)
|
2004-03-12 |
2013-09-17 |
Mti Meta Tech Inc. |
Methods for treating inflammatory bowel disease
|
|
US20070197430A1
(en)
|
2004-06-24 |
2007-08-23 |
Jonathan Baell |
Conjugates And Therapeutic Uses Thereof
|
|
EP1799705A4
(en)
|
2004-09-23 |
2008-11-05 |
Univ Melbourne |
Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
|
|
WO2006062685A2
(en)
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
|
WO2006058539A2
(en)
|
2004-11-30 |
2006-06-08 |
Gastrotech Pharma A/S |
Growth hormone secretagogue receptor 1a ligands
|
|
ES2818028T3
(es)
|
2004-12-20 |
2021-04-09 |
Antibodyshop As |
Determinación de lipocalina asociada a gelatinasa de neutrófilos (NGAL) como marcador diagnóstico para trastornos renales
|
|
US20100183617A1
(en)
|
2005-02-23 |
2010-07-22 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating sas1r
|
|
CA2549477A1
(en)
|
2005-06-29 |
2006-12-29 |
The Regents Of The University Of California |
Competitive regulation of hepcidin mrna by soluble and cell-associated hemojuvelin
|
|
JP2009509535A
(ja)
|
2005-09-27 |
2009-03-12 |
アムニクス， インコーポレイテッド |
タンパク様薬剤およびその使用
|
|
US7790862B2
(en)
|
2006-06-13 |
2010-09-07 |
Zymogenetics, Inc. |
IL-17 and IL-23 antagonists and methods of using the same
|
|
US8076306B2
(en)
|
2006-04-12 |
2011-12-13 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to hepcidin
|
|
JP2010527577A
(ja)
|
2006-05-22 |
2010-08-19 |
クリニカル ジェノミクス ピーティーワイ リミテッド |
検出方法
|
|
GB0610395D0
(en)
|
2006-05-25 |
2006-07-05 |
Ge Healthcare Ltd |
Novel imaging agents
|
|
US20080019913A1
(en)
|
2006-07-07 |
2008-01-24 |
University Of Arizona Office Of Technology Transfer |
Enkepahlin analogs with improved bioavailability
|
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
|
US7713937B2
(en)
|
2006-11-10 |
2010-05-11 |
Cara Therapeutics, Inc. |
Synthetic peptide amides and dimeric forms thereof
|
|
US9193790B2
(en)
|
2006-12-07 |
2015-11-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
|
|
TW201307390A
(zh)
|
2007-02-02 |
2013-02-16 |
Amgen Inc |
海帕西啶（ｈｅｐｃｉｄｉｎ）、海帕西啶拮抗劑及使用方法
|
|
CA2677932A1
(en)
|
2007-02-15 |
2008-08-21 |
Indiana University Research And Technology Corporation |
Glucagon/glp-1 receptor co-agonists
|
|
ES2708988T3
(es)
|
2007-02-23 |
2019-04-12 |
Merck Sharp & Dohme |
Anticuerpos anti-IL-23p19 obtenidos por ingeniería genética
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
EP2150564A2
(en)
|
2007-04-27 |
2010-02-10 |
ZymoGenetics, Inc. |
Antagonists to il-17a, il-17f, and il-23p19 and methods of use
|
|
US8313950B2
(en)
|
2007-05-21 |
2012-11-20 |
The Ohio State University Research Foundation |
Hepcidins as biomarkers for impending lupus nephritis flare
|
|
US20090131317A1
(en)
|
2007-06-22 |
2009-05-21 |
Affymax, Inc. |
Compounds and peptides that bind the trail receptor
|
|
JP2011501941A
(ja)
|
2007-07-06 |
2011-01-20 |
バロリゼイション エイチエスジェイ， ソシエテ アン コマンディテ |
Ｉｌ−２３レセプターのアンタゴニストおよびその使用
|
|
CN101358201A
(zh)
|
2007-07-31 |
2009-02-04 |
钱忠明 |
重组人铁调素腺病毒、其制备方法及应用
|
|
CN101307085B
(zh)
|
2007-08-01 |
2012-06-13 |
香港理工大学深圳研究院 |
抑制铁调素调节蛋白的siRNA、重组慢病毒及其应用
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
GR1006896B
(el)
|
2007-08-24 |
2010-07-20 |
Ελληνικο Ινστιτουτο Παστερ, |
Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
|
|
WO2009039185A1
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of Columbia University In The City Of New York |
Uses of immunologically modified scaffold for tissue prevascularization and cell transplantation
|
|
US20100280098A1
(en)
|
2007-10-05 |
2010-11-04 |
Juliano Rudolph L |
Receptor targeted oligonucleotides
|
|
JP2012507723A
(ja)
|
2008-11-03 |
2012-03-29 |
シェーリング コーポレイション |
炎症性腸疾患生物マーカーおよび関連治療方法
|
|
US8435941B2
(en)
|
2008-12-05 |
2013-05-07 |
The Regents Of The University Of California |
Mini-hepcidin peptides and methods of using thereof
|
|
DE102009007381A1
(de)
|
2009-01-29 |
2010-08-05 |
Amp-Therapeutics Gmbh & Co. Kg |
Antibiotische Peptide
|
|
US8999935B2
(en)
|
2009-02-11 |
2015-04-07 |
New York University |
Treatment of osteoporosis in peri- and post-menopausal women with hepcidin
|
|
CA2758264A1
(en)
|
2009-04-08 |
2010-10-14 |
Takeda Pharmaceutical Company Limited |
Neuromedin u derivative
|
|
TWI578992B
(zh)
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類
|
|
US20110142889A1
(en)
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
|
CA2787331A1
(en)
|
2010-01-25 |
2011-07-28 |
Hazel H. Szeto |
Aromatic-cationic peptides and uses of same
|
|
US10416172B2
(en)
|
2010-03-31 |
2019-09-17 |
Medical Diagnostic Laboratories, Llc |
Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
|
|
JP2011231085A
(ja)
|
2010-04-30 |
2011-11-17 |
Osaka Prefecture Univ |
環状ペプチド
|
|
US20130236977A1
(en)
|
2010-05-24 |
2013-09-12 |
Children's Medical Center Corporation |
Compositions and methods for plasma peptide analysis
|
|
IT1406051B1
(it)
|
2010-08-05 |
2014-02-06 |
D M G Italia S R L |
Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
|
|
EP2603232B1
(en)
|
2010-08-11 |
2019-09-25 |
Ironwood Pharmaceuticals, Inc. |
Stable formulations of linaclotide
|
|
EP2444101A1
(en)
|
2010-10-21 |
2012-04-25 |
Universitätsklinikum Freiburg |
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
|
|
EP2668199B1
(en)
|
2011-01-27 |
2017-09-06 |
Ramot at Tel Aviv University, Ltd. |
Glycogen synthase kinase-3 inhibitors
|
|
US8946150B2
(en)
|
2011-06-14 |
2015-02-03 |
Medical Diagnostic Laboratories, LLC. |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
CA2839408A1
(en)
|
2011-06-14 |
2012-12-20 |
Stealth Peptides International, Inc. |
Aromatic-cationic peptides and uses of same
|
|
US9169292B2
(en)
|
2011-06-14 |
2015-10-27 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US9605027B2
(en)
|
2011-06-14 |
2017-03-28 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
BR112014013697A2
(pt)
|
2011-12-09 |
2020-11-03 |
The Regents Of The University Of California |
peptídeos mini-hepcidina modificados e métodos de uso dos mesmos
|
|
WO2013177432A1
(en)
|
2012-05-23 |
2013-11-28 |
The University Of Chicago |
Methods of treating obesity
|
|
US9024044B2
(en)
|
2012-06-14 |
2015-05-05 |
Ajinomoto Co., Inc. |
Heteroarylcarboxylic acid ester derivative
|
|
US9273093B2
(en)
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
WO2014127316A2
(en)
|
2013-02-15 |
2014-08-21 |
Srx Cardio, Llc |
Proprotein convertase subtilisin/kexin type 9 (pcsk9) allosteric binding ligands to mudulate serum low density lipoprotein (ldl) levels
|
|
EP4091624A1
(en)
|
2013-03-15 |
2022-11-23 |
Protagonist Therapeutics, Inc. |
Hepcidin analogues and uses thereof
|
|
US20140294902A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide antagonists
|
|
US20140294901A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide dimer antagonists
|
|
RU2732440C2
(ru)
|
2013-06-24 |
2020-09-16 |
Кэнбас Ко., Лтд. |
Пептиды и пептидомиметики для комбинированного применения и лечения в субпопуляциях пациентов с раковыми заболеваниями
|
|
WO2014210056A1
(en)
|
2013-06-27 |
2014-12-31 |
Stealth Peptides International, Inc. |
Peptide therapeutics and methods for using same
|
|
US20160235807A1
(en)
|
2013-10-09 |
2016-08-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
|
|
WO2015112700A1
(en)
|
2014-01-22 |
2015-07-30 |
Wisconsin Alumni Research Foundation |
Alpha/beta-peptide mimics of z-domain peptides
|
|
EP3129040A4
(en)
|
2014-04-07 |
2018-03-21 |
La Jolla Pharmaceutical Company |
Hepdicin mimetic peptides and uses thereof
|
|
HRP20211448T1
(hr)
|
2014-05-16 |
2021-12-24 |
Protagonist Therapeutics, Inc. |
Alfa4beta7 integrin tioeter peptidni antagonisti
|
|
WO2015183963A2
(en)
|
2014-05-28 |
2015-12-03 |
Stealth Peptides International, Inc. |
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
WO2015200916A2
(en)
|
2014-06-27 |
2015-12-30 |
Protagonist Therapeutics, Inc. |
Hepcidin and mini-hepcidin analogues and uses therof
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
CN107206254B
(zh)
*
|
2014-07-17 |
2021-08-24 |
领导医疗有限公司 |
白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途
|
|
WO2016054411A1
(en)
|
2014-10-01 |
2016-04-07 |
Protagonist Therapeutics, Inc. |
NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
|
|
US10301371B2
(en)
|
2014-10-01 |
2019-05-28 |
Protagonist Therapeutics, Inc. |
Cyclic monomer and dimer peptides having integrin antagonist activity
|
|
EP3240799B1
(en)
|
2014-12-29 |
2021-03-31 |
The Regents of the University of California |
S-alkylated hepcidin peptides and methods of making and using thereof
|
|
US20160199437A1
(en)
|
2015-01-08 |
2016-07-14 |
D. Travis Wilson |
Therapeutic compositions including iron chelators and uses thereof
|
|
WO2016115168A1
(en)
*
|
2015-01-12 |
2016-07-21 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
|
US20160228491A1
(en)
|
2015-02-09 |
2016-08-11 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including phenazine-3-one and phenothiazine-3-one derivatives and uses thereof
|
|
WO2016195663A1
(en)
|
2015-06-02 |
2016-12-08 |
Stealth Peptides International, Inc. |
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof
|
|
WO2016200364A1
(en)
|
2015-06-08 |
2016-12-15 |
Stealth Peptides International, Inc. |
THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
|
|
US10787490B2
(en)
|
2015-07-15 |
2020-09-29 |
Protaganist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
MX384213B
(es)
*
|
2015-07-15 |
2025-03-14 |
Protagonist Therapeutics Inc |
Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias.
|
|
US20190002503A1
(en)
|
2015-12-30 |
2019-01-03 |
Protagonist Therapeutics, Inc. |
Analogues of hepcidin mimetics with improved in vivo half lives
|
|
CA3017926C
(en)
|
2016-03-23 |
2023-10-10 |
Protagonist Therapeutics, Inc. |
Methods for synthesizing .alpha.4.beta.7 peptide antagonists
|
|
WO2018022917A1
(en)
|
2016-07-27 |
2018-02-01 |
Protagonist Therapeutics, Inc. |
Disulfide-rich peptide libraries and methods of use thereof
|
|
WO2018022937A1
(en)
|
2016-07-27 |
2018-02-01 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
|
|
WO2018089693A2
(en)
*
|
2016-11-09 |
2018-05-17 |
Protagonist Therapeutics, Inc. |
Methods for determining and monitoring gastrointestinal inflammation
|
|
JP7100034B2
(ja)
|
2016-12-06 |
2022-07-12 |
シュティヒティング・ヴォール・デ・テクニシェ・ヴェテンシャッペン |
多環式ペプチド及びそれらの調製方法
|
|
WO2018136646A1
(en)
|
2017-01-18 |
2018-07-26 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
EP3681900A4
(en)
|
2017-09-11 |
2021-09-08 |
Protagonist Therapeutics, Inc. |
OPIOID AGONIST PEPTIDES AND THEIR USES
|
|
CA3089868A1
(en)
|
2018-02-08 |
2019-08-15 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
WO2019246273A1
(en)
|
2018-06-20 |
2019-12-26 |
Progenity, Inc. |
Treatment of a disease of the gastrointestinal tract with a jak or other kinase inhibitor
|
|
WO2020014646A1
(en)
|
2018-07-12 |
2020-01-16 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
CN113631569A
(zh)
|
2019-03-28 |
2021-11-09 |
领导医疗有限公司 |
用于合成β-高氨基酸的方法
|
|
JP7534382B2
(ja)
|
2019-07-10 |
2024-08-14 |
プロタゴニスト セラピューティクス， インコーポレイテッド |
インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用
|
|
WO2021007433A1
(en)
|
2019-07-10 |
2021-01-14 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
PH12022550510A1
(en)
|
2019-09-03 |
2023-09-04 |
Protagonist Therapeutics Inc |
Conjugated hepcidin mimetics
|
|
CA3166637A1
(en)
|
2020-01-10 |
2021-07-15 |
Protagonist Therapeutics, Inc. |
Methods for treating inflammatory bowel diseases with .alpha.4.beta.7 integrin antagonists
|
|
AU2021209086A1
(en)
|
2020-01-15 |
2022-08-04 |
Janssen Biotech, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
CA3167751A1
(en)
|
2020-01-15 |
2021-07-22 |
Janssen Biotech, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
WO2021146458A1
(en)
|
2020-01-15 |
2021-07-22 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
AU2021315564A1
(en)
|
2020-07-28 |
2023-02-09 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
JP7397239B2
(ja)
|
2020-11-20 |
2023-12-12 |
ヤンセン ファーマシューティカ エヌ．ベー． |
インターロイキン－２３受容体のペプチド阻害剤の組成物
|